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Introduction
Migraine is a chronic neurovascular disorder that, in
Western countries, affects approximately 15% of the gener-
al population [1]. The aetiology of migraine is still unknown
but several studies support a strong genetic basis for the dis-
ease [2]. Mutations in the CACNA1A and ATP1A2 genes are
associated with familial hemiplegic migraine, a rare subtype
of migraine with aura [3, 4]. The genes involved in the more
common form of migraine, like migraine with and without
aura, are still unknown.
Epidemiological studies have shown the presence of a sig-
nificant comorbidity between migraine and some diseases
related to the HLA system, like asthma and narcolepsy [5, 6].
This comorbidity suggests the presence, within the HLA
region, of genetic factors involved in the disease pathogenesis.
Previous studies evaluating the relation between HLA
system and migraine provided conflicting results [7, 8].
Recently, a significant association was found between
migraine and polymorphisms of two genes, TNF-alpha and
TNF-beta, located in the HLA Class III region [9, 10].
To further investigate this issue, we performed an asso-
ciation study between polymorphisms of the HLA-DRB1
gene and migraine in a large cohort of Italian migraine
patients. The purpose of this study was to assess whether
HLA-DRB1 alleles confer susceptibility to migraine or are
related to specific clinical subgroups.
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Abstract We examined the distrib-
ution of HLA-DRB1 alleles in a
cohort of 255 Italian migraine
patients and in a control group of
325 healthy subjects. The frequency
of DRB1*12 allele was found to be
significantly reduced (p=0.02) in
patients with migraine while the
DRB1*16 allele was significantly
increased (p=0.04) in comparison
with controls. When the patients
were divided into disease subgroups
(migraine with and without aura),
HLA-DRB1**16 allele was signifi-
cantly increased (p<0.05) only in
migraine without aura patients. We
conclude that, in Italian patients,
migraine is associated with differ-
ent alleles of the HLA-DRB1 locus.
Our data suggest the presence of a
genetic susceptibility factor for
migraine within the HLA region.
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Materials and methods 
Two hundred and fifty-five consecutive migraine patients (77 males,
178 women; mean age±SD=40.87±13.10 years) attending the
Headache Center of the University of Turin (Italy), were involved in
the study. The diagnosis of migraine was made according to the
International Classification of Headache Disorders (ICHD-II) crite-
ria [11]. For additional analyses, migraine patients were divided into
2 subgroups: (A) migraine without aura (ICHD-II code 1.1), 214
patients (65 males, 149 females; mean age±SD=41.5±12.0 years);
and (B) migraine with aura (ICHD-II code 1.2), 41 patients (12
males, 29 females; mean age±SD=36.4±13.6 years). A group of 325
age and geographically matched healthy subjects (151 males, 174
females, mean age±SD=41.96±14.86 years) served as control. The
controls were blood donors and were screened by a neurologist spe-
cialised in headaches in order to exclude migraine and/or cluster
headache. The protocol of this study was reviewed and approved
by the Medical Ethics Committee of the San Giovanni Battista
Hospital of Turin and written informed consent was obtained from
all participants.
Genomic DNA was extracted from EDTA-treated blood
using a commercial DNA extraction kit (QiAmp blood kit;
Kagan, Crawley, UK). HLA-DRB1 typing was performed at the
two-digit level by PCR amplification using specific probes and
primers (Dynal Biotech Ltd., Bromborough, Wirral, UK). The
Hardy-Weinberg equilibrium was verified for all tested popula-
tions. Statistical analyses were performed using SigmaStat ver-
sion 1.0 (Jandel Corp., 1994, San Rafael, CA). A level of p<0.05
was accepted as statistically significant.
Results
Table 1 shows the distribution of HLA-DRB1 alleles in
migraine patients and controls. The phenotypic frequen-
cies of HLA-DRB1 alleles were similar to those previous-
ly found in the Italian population [12]. In patients with
migraine, the frequency of the HLA-DRB1*12 allele was
found to be significantly lower than in controls (χ2=5.03,
p=0.025, OR: 0.28, 95% CI: 0.08–0.88). The frequency of
HLA-DRB1*16 was significantly higher (χ2=4.10,
p=0.043, OR: 1.80, 95% CI: 1.02–3.19) in migraine
patients. No significant difference was found in the
remaining alleles.
Table 2 shows the comparison of HLA-DRB1 alleles
between migraine subgroups and healthy controls. In
Table 1 HLA-DRB1 allele distribution in migraine patients and controls
Allele Migraine patients (n=255) Healthy controls (n=325) p OR (95% CI)
DRB1*01 42 58 0.74
DRB1*03 38 52 0.81
DRB1*04 46 58 0.96
DRB1*07 52 82 0.24
DRB1*08 11 16 0.88
DRB1*09 1 1 0.59
DRB1*10 11 5 0.08
DRB1*11 136 174 0.98
DRB1*12 4 18 0.025 0.28 (0.08–0.88)
DRB1*13 60 73 0.85
DRB1*14 40 34 0.10
DRB1*15 36 55 0.39
DRB1*16 33 24 0.043 1.80 (1.02–3.19)
Table 2 Comparison of HLA-DRB1 allele distribution between controls and migraine subgroups














*OR: 1.97; 95% CI: 1.10<OR<3.54
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migraine without aura patients, the frequency of the *16
allele was significantly (χ2=5.35, p=0.045, OR: 1.97, 95%
CI: 1.10–3.54) increased in comparison with controls. No
significant difference in HLA-DRB1 allele distribution was
found in the remaining subgroups.
Discussion
Our study shows the presence of a significant association
between alleles of the HLA-DRB1 gene and migraine.
Subjects carrying the *12 allele of this gene present a sig-
nificant reduction in the risk for migraine, suggesting a
protective role for the disease. On the contrary, the carriage
of the *16 allele is associated with a two-fold increase in
disease risk. When the migraine patients were divided into
subgroups (migraine with and without aura), only migraine
without aura patients presented a significant increase of the
*16 allele. These alleles may be considered as risk factors
for migraine without aura in the Italian population. In a
previous study, Martelletti et al. [13] genotyped 45
migraine patients for HLA-DRB1 alleles and found no sig-
nificant difference with controls. The number of patients
examined in this study was probably too low for the detec-
tion of a statistically significant difference.
The most likely explanation of our data is that the DRB1
locus is in linkage disequilibrium (LD) with other genetic
polymorphisms which are responsible for this association.
The DRB1 gene is located on chromosome 6p21, within the
HLA-Class III region, and this region is characterised by a
high LD [14]. Further studies, using different methods for
HLA analysis, are needed to confirm the presence of sus-
ceptibility genes for migraine in this genomic region.
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